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Introduction
Restless legs syndrome (RLS) is a common sleep disorder, with an 
estimated prevalence of  5 to 10% of  the adult population.1–3 RLS 
is defined as an urge to move the legs when resting or lying down, 
 especially at night, that is relieved by activity.1 The pathophysiologic 
basis of  RLS is poorly understood. Previous studies have identified a vari-
ety of  both central and peripheral nervous system abnormalities in 
patients with RLS. Regarding central nervous system factors, the most 
consistent risk factor linked to RLS is reduced central iron stores, even in 
the setting of  normal systemic iron studies, suggesting a perturbation in 
homeostatic mechanisms that regulate the iron influx and/or efflux from 
the cell.4 Likewise, alterations in dopaminergic systems, likely attributed to 
an increased dopamine turnover in RLS;5 and circadian disruption with 
increased circadian dopaminergic variation,6, 7 are also plausible mecha-
nisms. Regarding peripheral nervous system, hyperalgesia characterized 
by elevated pinprick pain rating scores in the legs, has been associated 
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Abstract
Background: Restless legs syndrome (RLS) is a common sleep disorder,. although controversial, growing evidence relates the presence of  RLS to an increased 
risk of  mortality, mainly due to cardiovascular events. The aim of  this article was to review the role of  RLS as a risk factor of  mortality according to independent 
cohort studies.
Methods: We performed a literature review via PubMed database for articles relating RLS and mortality. We used the random-effects model to calculate the 
pooled effect estimates on mortality. Heterogeneity between studies was assessed using quantitative and qualitative analysis.
Results: Out of  100 articles identified, 13 were finally included. Although studies were heterogeneous (p = 0.001), no significant publication bias was found. 
When all cohort studies were considered, the random-effects model yielded a significantly increased risk of  mortality in RLS versus non-RLS patients (13 studies, 
hazard ratio [HR] = 1.52, 95% confidence interval [CI] 1.28–1.80). However, this association was not statistically significant when only cohort studies using the 
international RLS diagnostic criteria were considered (5 studies, HR = 1.63, 95% CI 0.94–2.81).
Discussion: The results of  this meta-analysis suggest that RLS seems to be a risk factor of  mortality, although this association is conditioned by the diagnostic 
criteria used in the studies. Future long-term follow-up standardized mortality studies are needed to address this important question that carries potential impact on 
population global health.
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with central sensitization to A-delta fiber high-threshold mechanorecep-
tor input, a characteristic sign of  the hyperalgesic neuropathic pain 
present in RLS.4 
The most common comorbid conditions associated with RLS include 
systemic iron deficiency (low serum ferritin levels <50 mcg/L and sub-
sequent low central nervous system intracellular iron),8 renal failure with 
uremia, frequently associated with periodic limb movements of  sleep 
indices,9 neuropathy,10 spinal cord pathology,11 pregnancy,12 multiple 
sclerosis,13 Parkinson´s disease and essential tremor.14,15 RLS is a treat-
able condition, that generally responds well to pharmacologic treatment 
including iron therapy and non-ergot dopamine agonists or alpha-2-
delta calcium channel ligands, as the first line therapy, concurrent with 
avoidance of  mental alerting activities, and stimulant substances like 
caffeine. 
A growing body of  evidence relates RLS to an increased risk of  mor-
tality attributable to both cerebrovascular and cardiovascular events,16,17 
likely mediated by sympathetic hyperactivity,18 or linked to other chronic 
conditions (e.g., obesity, depression, and disability).19–22 However, this 
relationship has not been confirmed by others.23–25 Assessment and 
identification of  RLS as a modifiable mortality risk factor carries 
important public health implications and suggests the need for RLS 
screening and monitoring. The aim of  this study was to quantitatively 
review the association between RLS and global mortality according to 
the results of  eligible independent cohort studies. 
Methods
Search strategy and eligibility criteria
Search strategy and meta-analysis followed the PRISMA  guidelines.26 
We searched the PubMed database using the search terms “mortality,” 
“survival” and “RLS,” and “Willis–Ekbom disease.” The search was 
restricted to English and Spanish language articles involving human 
subjects, reviews, and meta-analysis, and prospective studies, in which 
these terms appeared in the title or abstract, and were published 
between January 1, 1950 and January 15, 2019. We also reviewed 
cross-references of  selected publications for added perspective. In the 
meta-analysis, we only included prospective observational studies 
reporting regression analysis and hazard ratios (HR) for mortality with 
95% confidence interval (CI). We excluded all case reports and observa-
tional studies not providing the aforementioned HR.
Data extraction
All relevant articles were independently evaluated by all of  the 
authors, and disagreements were resolved by consensus. Data extracted 
from each study included first author, year of  publication, population, 
number of  participants, type of  study design, criteria for RLS diagnosis, 
HR (95% CI) for mortality, possible confounding variables, advantages, 
and disadvantages.
Statistical analysis
HR for mortality of  each selected study was recorded and pre-
sented in a forest plot graph. A pooled HR with a 95% CI was calcu-
lated based on data extracted from each study. A random-effects 
DerSimonian Laird model and the Galbraith plot were used to calcu-
late the pooled effect estimates.27 We assessed heterogeneity between 
studies using the Cochran’s Q and I2 statistics, and statistical signifi-
cance was considered with a p-value <0.001. For the qualitative inter-
pretation of  heterogeneity between studies, the funnel plot inspection28 
and the Begg’s and Egger’s statistical tests29 were performed. Epidat 
version 3.1 software (Servicio Gallego de Salud, Spain) was used for 
statistical analysis.
Results
Study selection and description
An initial screening of  the papers yielded 68 articles eligible for anal-
ysis. After excluding non-longitudinal studies and those not matching 
the inclusion criteria, a total of  13 studies were finally selected and 
included in the meta-analysis (Figure 1). Table 1 shows the main  features 
of  the studies including the sample size; population type including gen-
eral community versus end-stage renal disease, gender; RLS assessment 
criteria; HR (95% CI) for mortality as the primary outcome measure; 
covariates included in each multivariate Cox regression analysis; and 
the strengths and weaknesses of  each study. Figure 2 shows the 
Forest Plot graph of  eligible studies. The diagnosis of  RLS was estab-
lished using the International Restless Legs Syndrome Study Group 
(IRLSSG) diagnostic criteria30 in five studies (35.7%).31–35 In nine studies 
(64.3%), the diagnosis of  RLS was based on self-administered ques-
tionnaires,4,36–38 ICD-9 codes,5,39 and other sleep quesionnaires.40,41 
The results of  11 studies (78.6%)4,5,31–34,36,37,40,41 supported RLS as a risk 
factor for increased mortality. The opposite conclusion was found in 
only three studies (21.4%).35,38,39
Records idenfied through PubMed database 
searching (1950 to January Week 3 2019)
N=100









Figure 1. Prisma Flow Diagram for Identification of  Relevant Studies. 
Reasons for exclusion: *=non-longitudinal studies; **=abstracts, non-matched 
inclusion criteria studies, language (non-English or Spanish).
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Figure 2. (A) Forest Plots on the Adjusted Hazard Ratio (95% Confidence Intervals) for Mortality in Patients Diagnosed with Restless Legs 
Syndrome in 13 RLS Cohort Studies. (B) Forest plots on the adjusted hazard ratio (95% confidence intervals) in five RLS cohort studies using the IRLSSG 
diagnostic criteria. (C) Forest plots on the adjusted hazard ratio (95% confidence intervals) in seven RLS end-stage renal disease cohort studies. (D) Forest plots on the 
adjusted hazard ratio (95% confidence intervals) in six RLS general community cohort studies.
Meta-analysis
Significant heterogeneity between studies was present and confirmed 
with the Cochran’s Q test (p = 0.0003). According to the random-effects 
model including the 13 selected cohort studies, the pooled HR for 
 mortality in patients with RLS compared to non-RLS was HR = 1.52 
(95% CI 1.28–1.80) (Figure 2A). Three subgroup analyses were subse-
quently conducted. The first subgroup analysis included only studies 
using the IRLSSG diagnostic criteria (n = 5).30 Among this subset of  
studies,  heterogeneity was present (Cochran’s Q test, p = 0.001), and the 
pooled HR of  mortality favored the association between RLS and 
 mortality, however not reaching statistical significance (HR = 1.63, 95% 
CI 0.94–2.81) (Figure 2B). The second subgroup analysis included 
end-stage renal disease-based studies (n = 7). Heterogeneity was also 
present (Cochran’s Q test, p = 0.004), and the pooled HR confirmed a 
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statistically significant association between RLS and mortality: 
HR = 1.41, 95% CI 1.05–1.87 (Figure 2C). The third subgroup analysis 
included community-based studies. However, in this case, heterogeneity 
was not present (Cochran’s Q test, p = 0.45), and the pooled HR con-
firmed the association between RLS and mortality: HR = 1.80, 95% 
CI 1.65–1.97 (Figure 2D). Visual inspection of  the funnel plots 
(Figures 3A, 3B, 3C, and 3D) and Egger graphs (Figures 4A, 4B, 4C, 
and 4D) showed no evidence of  significant publication bias regarding 
both the total group and subgroup analysis (Begg’s test, p = 0.07, 0.08, 
0.13, 0.10; Egger’s test, p = 0.35, 0.32, 0.30, 0.21, respectively).
Discussion
The real factors that determine survival in RLS are not well estab-




Figure 3. (A) Funnel Plot in 13 RLS Cohort Studies. (B) Funnel plot in five RLS cohort studies using the IRLSSG diagnostic criteria. (C) Funnel plot in seven 
RLS end-stage renal disease cohort studies. (D) Funnel plot in six RLS general community cohort studies.
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Figure 4.  (A) Egger Graph in 13 RLS Cohort Studies. (B) Egger graph in five RLS cohort studies using the IRLSSG diagnostic criteria. (C) Egger graph in 
seven RLS end-stage renal disease cohort studies. (D) Egger graph in six RLS general community cohort studies.
between RLS and mortality. Previous cohort studies are conditioned by 
several factors, such as a limited number of  patients, the characteristics of  
the study population (either from the general population or belonging to 
end-stage renal subsets of  patients), and the relatively short  follow-up 
duration, resulting in rather few observed deaths. In this meta-analysis 
including 13 cohort studies, using different RLS diagnostic criteria, we 
observed a higher risk of  mortality among patients presenting RLS, likely 
associated with cardiovascular diseases and especially in women, com-
pared to non-RLS population. In contrast, mortality was not significantly 
different when the meta-analysis was restricted to RLS studies that used 
the IRLSSG diagnostic criteria.30 A thorough review of  the literature pro-
vides relevant information about the factors affecting this relationship.
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Methodological issues
Although the results of  the cohort studies included in this review 
were controlled for several known risk factors, these observational 
 studies were not primarily designed to confirm causality. To assess the 
presence of  RLS, earlier studies used mailed self-reporting question-
naires, a well-known and relatively inexpensive diagnostic screening 
method that is limited by diagnostic accuracy.7 In fact, one study 
showed that the four main criteria for the  diagnosis of  RLS applied 
to the general population, and not undergoing adequate differential 
diagnosis, wrongly classify 16% of  healthy participants as having 
RLS.42 Similarly, the diagnostic accuracy of  ICD-9 RLS codes is yet 
unknown.
Interview-based diagnosis using accepted international RLS diag-
nostic criteria30,43 is key to provide standardized RLS assessment across 
populations. Some years ago, the members of  the Movement Disorder 
Society Committee on Rating Scales published a review article about 
the diagnostic instruments for RLS and provided recommendations 
based on the available evidence at that time.44 In this regard, an RLS 
survival study4 used a single question, included in the original diagnostic 
criteria for RLS, that was primarily developed for rapid screening of  
patients in a clinical setting.44,45 Based on its excellent sensitivity (100%) 
and specificity (96.8%),45 this single question may be considered a pre-
liminary reliable screener for the diagnosis of  RLS, needing subsequent 
confirmation by routine clinical interview.44 To improve the diagnostic 
accuracy, other studies33,34 have included the RLS diagnostic index with 
10 items, which was developed to test the possibility that ancillary 
non-essential features may help to perform a more accurate diagnosis 
within the clinical setting, with a sensitivity of  93% and a specificity 
of  98.9%.46 Other diagnostic tests, recommended for clinical use 
(Cambridge Hopkins diagnostic questionnaire),30 and also for the gen-
eral population (Hening Telephone Diagnostic Interview),47 exhibit 
excellent diagnostic attributes, although they have not been used in RLS 
survival studies.
Selection bias, like increased mortality found only in women, may be 
attributed to the fact that overall mortality in men generally exceeds that 
of  women, and any factor influencing mortality in men needs to be 
more pronounced.40 On the contrary, as RLS is a commonly underdiag-
nosed condition,48 there is a tendency to include more severely affected 
patients, which might overestimate the true effect of  RLS on global 
mortality. Moreover, the exact cause of  death and the follow-up  duration 
are not always clearly reported.
Regarding statistical methodology, the results of  a multivariate Cox 
regression and propensity score method analysis can only account for 
the effects of  known confounders. Therefore, there is a need for well- 
designed mortality studies analyzing age–sex standardized mortality 
ratios (SMR),49 in which observed deaths within RLS cohorts compared 
to expected deaths in the general population are reported.
End-stage renal disease versus community-based 
RLS populations
Due to the heterogeneity present among studies, we conducted sev-
eral subgroup analyses. Among end-stage renal and community-based 
populations, RLS was associated with a significantly increased 
 mortality. According to some studies, the association between RLS 
and mortality seems to be influenced by advanced age, the presence of  
cardiovascular risk factors, end-stage renal disease, and other sleep-re-
lated conditions. However, the results provided by studies based on 
end-stage renal disease subjects may not be comparable to other rela-
tively healthier populations. In community-based mortality studies, 
the mechanisms affecting survival in the RLS subpopulation are not 
well understood. Maintenance of  the normal rest/activity circadian 
rhythm appears to be of  particular importance for the preservation of  
general health.50 Accordingly, an increased risk of  total mortality and 
coronary artery disease mortality has been found in RLS men present-
ing insomnia.38,40 Possible mechanisms linking insomnia and impaired 
global health include activation of  inflammatory cytokines such as 
serum C-reactive,51 and changes of  circulating levels of  leptin and 
ghrelin proteins, which promote the development of  obesity, diabetes, 
and cardiovascular disease.52,53 RLS patients exhibit dopamine distur-
bances that correlate with decreased function of  the A11 diencephalo-
spinal pathway, resulting in disinhibition of  somatosensory and 
sympathetic pathways of  the spinal cord. This may lead to an increased 
sympathetic activation, causing hypertension, cardiovascular disease, 
and stroke.6,51 Other studies relate the presence of  periodic limb 
 movements of  sleep in RLS with nocturnal hypertension without a 
dipping pattern, which strongly correlates with left ventricular 
hypertrophy.54,55 
Strengths and limitations
In this review, we followed the PRISMA guidelines,26 applied to the 
search strategy, and used a well-validated meta-analytic methodology. 
Although cohort studies showed differences in their sampling proce-
dures, sample characteristics, and adjustment for confounding factors, 
no significant publication bias was found, allowing comparability 
between studies. However, several limitations have to be considered 
when interpreting our results, including the lack of  well-defined diag-
nostic criteria of  RLS in some studies, the inclusion of  mixed primary 
and secondary RLS studies, the possibility of  having included patients 
with conditions mimicking RLS like diabetic neuropathy, and the small 
number of  studies included in the subgroup analyses, which limit the 
extrapolation of  our findings.
Conclusions
RLS is currently an under-recognized condition, especially by 
 primary care physicians. The association between RLS and increased 
mortality has potential impact on population global health. Currently, 
there is a need for well-designed mortality studies addressing the 
SMR and the influence of  any RLS-specific therapy on mortality and 
comorbidity. The results of  this review suggest an association between 
RLS and increased mortality, although the existence of  this associa-
tion depends on the diagnostic criteria of  the studies included in 
the analysis. Increasing awareness of  RLS and future long-term 
 follow-up standardized mortality studies is needed to confirm these 
findings.
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